From the Restart Study Presentation $193m drawdown facility with $149m pre production capital cost
Agree @Da12kl0rd and once finance is approved and Barry indicating a Sulphide Scoping Study to be forthcoming by year end, we could well see value attributed to the MC when that arrives.
All in all the risk to the upside outweighs the negative possibilities.
For those that are worried about the downside possibilities you always have the option to sell and remove those concerns to your portfolio.
CYM Price at posting:
18.0¢ Sentiment: Buy Disclosure: Held
